AdaptHealth director gifts 73,472 shares

AdaptHealth Corp. director Susan T. Weaver reported a bona fide gift of 73,472 shares of AdaptHealth common stock, transferred to the Susan T. Weaver 2025 Irrevocable Trust for the benefit of her spouse and children.

Rhea-AI Filing Summary

AdaptHealth Corp. director Susan T. Weaver reported a bona fide gift of 73,472 shares of AdaptHealth common stock, transferred to the Susan T. Weaver 2025 Irrevocable Trust for the benefit of her spouse and children. The filing lists the transaction as a gift transfer with no sale price.

After these transactions, Weaver directly holds 21,346 shares of AdaptHealth common stock and indirectly holds 73,472 shares through the irrevocable trust, reflecting a shift of ownership to a family estate-planning vehicle rather than a market sale.

Insider Trade Summary

146,944 shares gifted

Gift 2 txns

Insider Weaver Susan T

Role Director

Type	Security	Shares	Price	Value
Gift	Common Stock	73,472	$0.00	$0.00
Gift	Common Stock	73,472	$0.00	$0.00

Holdings After Transaction: Common Stock — 21,346 shares (Direct); Common Stock — 73,472 shares (Indirect, By Irrevocable Trust)

Footnotes (1)

1. F1. On March 5, 2025, the reporting person transferred 73,472 shares of AdaptHealth Corp. common stock to the Susan T. Weaver 2025 Irrevocable Trust, of which the reporting person's spouse and son are the co-trustees and the reporting person's spouse and children are the beneficiaries.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AdaptHealth (AHCO) disclose for Susan T. Weaver?

AdaptHealth reported that director Susan T. Weaver made a bona fide gift transfer of 73,472 shares of AdaptHealth common stock to a family irrevocable trust, shifting ownership without an open-market sale or purchase.

How many AdaptHealth (AHCO) shares did Susan T. Weaver gift?

Susan T. Weaver transferred 73,472 shares of AdaptHealth common stock as a bona fide gift. The shares were moved to the Susan T. Weaver 2025 Irrevocable Trust, benefiting her spouse and children rather than being sold in the market.

What is the Susan T. Weaver 2025 Irrevocable Trust mentioned in the AHCO Form 4?

The filing states that 73,472 AdaptHealth shares were transferred to the Susan T. Weaver 2025 Irrevocable Trust, whose co-trustees are her spouse and son, and whose beneficiaries are her spouse and children, indicating a family estate-planning vehicle.

How many AdaptHealth (AHCO) shares does Susan T. Weaver hold after the reported gift?

Following the reported transactions, Susan T. Weaver holds 21,346 shares of AdaptHealth common stock directly and 73,472 shares indirectly through the irrevocable trust, according to the share balances listed after the gift transfer.

Was Susan T. Weaver’s AdaptHealth (AHCO) transaction a sale or a gift?

The transaction is classified as a bona fide gift, not a sale. The Form 4 uses transaction code "G" and describes the action as a gift transfer, with a per-share price of 0.0000, indicating no sale proceeds.

At what price were the gifted AdaptHealth (AHCO) shares transferred?

The gifted AdaptHealth shares were transferred at a reported price of $0.0000 per share. This aligns with the Form 4 classification of the transaction as a bona fide gift rather than an open-market sale or purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/09/2026 - 09:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weaver Susan T

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PA 19428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		G		73,472	D	$0	21,346	D
Common Stock	03/05/2026		G		73,472	A	$0	73,472	I	By Irrevocable Trust(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On March 5, 2025, the reporting person transferred 73,472 shares of AdaptHealth Corp. common stock to the Susan T. Weaver 2025 Irrevocable Trust, of which the reporting person's spouse and son are the co-trustees and the reporting person's spouse and children are the beneficiaries.

	/s/ Richard Rew, as attorney-in-fact for Susan Weaver	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.